Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration. 1977

D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien

Amoxicillin was studied in normal subjects after intravenous, oral, and intramuscular administration of 250-, 500-, and 1,000-mg doses. Serum drug levels were analyzed using a two-compartment open model, as well as area under the curve (AUC) and urinary recovery. The variations of these pharmacokinetic parameters were then examined using the three-way analysis of variance and linear regression equations. These results confirmed nearly complete oral absorption: AUC was 93% of intravenous absorption, and urinary recovery was 86%. The intramuscular administration of amoxicillin results in complete and reliable absorption with peak drug levels, AUCs, and urinary recovery equivalent to oral dosage. The absorption of lyophilized amoxicillin after intramuscular injection resulted in an AUC that was 92% of intravenous absorption and urinary recovery of 91%. The peak serum levels, time to peak, and other pharmacokinetic parameters for intramuscular injection were nearly identical to those for oral administration. Kinetics of both intramuscular and oral administration exhibited dose-dependent absorption (absorption rate constant, 1.3/h for 250 mg and 0.7/h for 1,000 mg). This resulted in relatively later and lower peak serum levels for increasing dose. Total absorption, however, showed no dose dependence, as indicated by urinary recovery and AUC, which changed by less than 10%.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333

Related Publications

D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
October 1988, American journal of veterinary research,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
January 1981, Arzneimittel-Forschung,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
June 2007, Journal of veterinary pharmacology and therapeutics,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
April 2016, Journal of veterinary pharmacology and therapeutics,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
January 1998, Research in veterinary science,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
January 1988, Clinical pharmacy,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
October 1998, Journal of veterinary pharmacology and therapeutics,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
February 2008, Journal of veterinary pharmacology and therapeutics,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
August 1977, The Journal of pharmacology and experimental therapeutics,
D A Spyker, and R J Rugloski, and R L Vann, and W M O'Brien
January 1985, Materia medica Polona. Polish journal of medicine and pharmacy,
Copied contents to your clipboard!